Product Images Aripiprazole

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Aripiprazole NDC 62332-103 by Alembic Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - aripiprazole 1figure

Figure 1 - aripiprazole 1figure

This is a table that shows the effect of different drugs on aripiprazole, a medication used for treating symptoms of schizophrenia and bipolar disorder. The drugs included in the table are categorized according to their interaction with specific enzymes involved in the metabolism of aripiprazole. The table displays changes in the amount of aripiprazole (reported as fold change) relative to a reference value (without interacting drug). Additionally, the table reports the maximum concentration of some of the interacting drugs in the blood (Cmax). The drugs listed include ketoconazole, sunitinib, carbamazepine, and famotidine, among others.*

Figure 2 - aripiprazole 2figure

Figure 2 - aripiprazole 2figure

Figure 4 - aripiprazole 4figure

Figure 4 - aripiprazole 4figure

This seems to be data from a study concerning special populations and their response to a certain medication. The data include variables such as age, gender, hepatic impairment, renal impairment and metabolizer status. There is also a graph showing the fold change in the medication's effects. However, without more context or information, it is difficult to provide a more specific description or analysis of the data.*

Figure 5 - aripiprazole 5figure

Figure 5 - aripiprazole 5figure

aripiprazole-6figure.jpg - aripiprazole 6figure

aripiprazole-6figure.jpg - aripiprazole 6figure

This is a chart displaying the proportion of subjects with relapse for Aripiprazole and Placebo. It also provides the number of subjects at risk for each group over a 182-day period.*

aripiprazole-7figure.jpg - aripiprazole 7figure

aripiprazole-7figure.jpg - aripiprazole 7figure

This appears to be a graph with two lines, one labeled "Aripiprazole" and the other labeled "Placebo". The x-axis is labeled "Days from Randomization" and the y-axis is labeled "Proportion with Relapse". The data points for the Aripiprazole line are 83, 74, 62, 56, 53, 52, 48, 45, 41 (corresponding to the x-axis values of 14, 28, 42, 56, 70, 84, 98, 112, 126) and the data points for the Placebo line are 75, 61, 58, 50, 47, 46, 43, 42 (corresponding to the x-axis values of 14, 28, 42, 56, 70, 84, 98, 112). The rest of the text seems to be describing the graph so is not relevant for generating the description.*

Figure 3 - aripiprazole figure3

Figure 3 - aripiprazole figure3

aripiprazole mg 15

aripiprazole mg 15

aripiprazole mg10

aripiprazole mg10

Structure - aripiprazole str

Structure - aripiprazole str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.